TrialIn vivo (Athens, Greece)
Bevacizumab and Atezolizumab for Unresectable Hepatocellular Carcinoma: Real-world Data in Taiwan-Tainan Medical Oncology Group H01 Trial.
Yang-Cheng Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
cites it